Stock Comments / EPS Changes

ADT (ADT) estimates, price target were cut at Credit Suisse. Shares are now seen reaching $42. Estimates were also reduced, given the company's new guidance, Credit Suisse said. Outperform rating.

Buckeye Partners (BPL) 12-month price target was raised at UBS. Raised to reflect investments in growth projects, UBS said. Twelve-month price target is $76. Buy rating.

CBOE (CBOE) estimates, price target were increased through 2015 at BMO Capital. Company is keeping a tight lid on costs, BMO Capital said. Market Perform rating.

Cigna (CI) price target, EPS estimates were lowered at Jefferies. Driven by elevated MA costs, Jefferies said. Twelve-month price target is $86. Hold rating.

Cigna estimates, price target were reduced at Credit Suisse. Twelve-month price target is now $91. Estimates were also cut, as the company will likely face margin pressure, Credit Suisse said. Outperform rating.

Exelon (EXC) price target, EPS estimates were raised at UBS. Twelve-month price target is $28. Driven by exceptionally strong Boston capacity price data and strong 2014 guidance, UBS said.

Fiserv (FISV) 12-month price target, EPS estimates were lowered at Jefferies. Driven by margin softness with increased business development, Jefferies said. Twelve-month price target is $64. Buy rating.

Moody's (MCO) estimates, 12-month price target was boosted at Benchmark. Price target is now $81. Estimates were also increased, given higher bond issuance activity, Benchmark said. Hold rating.

Owens Corning (OC) price target, EPS estimates were trimmed at Jefferies. Reflects softer roofing demands due to bad weather, Jefferies said. Twelve-month price target is $51. Buy rating.

Omega Healthcare Investors (OHI) 12-month price target, EPS estimates were raised at Jefferies. Solid pipeline to drive spread investing, which will drive earnings growth, Jefferies said. Twelve-month price target is $32. Hold rating.

Olin (OLN) 12-month price target was increased at UBS. Driven by ongoing strength in ammo against increasing weakness in chlorine products, UBS said. Twelve-month price target is $25. Neutral rating.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

If you liked this article you might like

How to Get Rich Using Warren Buffett's Favorite Stock Market Indicators

How to Live Just Like Billionaire Warren Buffett

How to Make a Deal Like Billionaire Investor Warren Buffett

How to Invest Like Billionaire Warren Buffett

How to Eat Lunch With Billionaire Warren Buffett